LTIP580A - Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which results from vascular lesions - Google Patents

Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which results from vascular lesions

Info

Publication number
LTIP580A
LTIP580A LTIP580A LTIP580A LTIP580A LT IP580 A LTIP580 A LT IP580A LT IP580 A LTIP580 A LT IP580A LT IP580 A LTIP580 A LT IP580A LT IP580 A LTIP580 A LT IP580A
Authority
LT
Lithuania
Prior art keywords
glutaminate
pyridoxal
phosphate
magnesium
diseases
Prior art date
Application number
LTIP580A
Inventor
Werner Schneider
Britta Meyer
Erich F Elstner
Original Assignee
Steigerwald Arzneimittelwerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk filed Critical Steigerwald Arzneimittelwerk
Publication of LTIP580A publication Critical patent/LTIP580A/en
Publication of LT3335B publication Critical patent/LT3335B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to the use of magnesium-pyridoxal-5'-phosphate-glutaminate to prepare a pharmaceutical suitable for the reduction of LDL-bound peroxides and for the prophylaxis of vascular lesions resulting therefrom in the absence of hypercholesteraemia or hyperlipidaemia.
LTIP580A 1990-05-25 1993-05-31 Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which results from vascular lesions LT3335B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4016963A DE4016963A1 (en) 1990-05-25 1990-05-25 USE OF MAGNESIUM PYRIDOXAL 5'-PHOSPHATE GLUTAMINATE TO PREVENT ILLNESSES ARISING AS A RESULT OF DISSOLUTION

Publications (2)

Publication Number Publication Date
LTIP580A true LTIP580A (en) 1994-12-27
LT3335B LT3335B (en) 1995-07-25

Family

ID=6407228

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP580A LT3335B (en) 1990-05-25 1993-05-31 Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which results from vascular lesions

Country Status (28)

Country Link
US (1) US5372999A (en)
EP (1) EP0458287B1 (en)
JP (1) JPH07119174B2 (en)
KR (1) KR970005180B1 (en)
CN (1) CN1050750C (en)
AT (1) ATE142884T1 (en)
AU (1) AU651108B2 (en)
CA (1) CA2043228C (en)
CZ (1) CZ280683B6 (en)
DE (2) DE4016963A1 (en)
DK (1) DK0458287T3 (en)
EG (1) EG19730A (en)
ES (1) ES2091262T3 (en)
GR (1) GR3021077T3 (en)
HR (1) HRP931445B1 (en)
HU (1) HU219223B (en)
IE (1) IE76728B1 (en)
IL (1) IL98156A (en)
IN (1) IN173057B (en)
LT (1) LT3335B (en)
LV (1) LV10046B (en)
MD (1) MD306C2 (en)
MX (1) MX171883B (en)
RU (1) RU2041713C1 (en)
SI (1) SI9110925A (en)
SK (1) SK278896B6 (en)
UA (1) UA26973A1 (en)
ZA (1) ZA913692B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19527820A1 (en) * 1995-07-28 1997-01-30 Leniger Follert Elfriede Prof Medicines for the treatment of ulcers, especially in the case of arterial and venous circulatory disorders in the extremities, in chronic venous insufficiency and lymphedema
DE19532625C2 (en) * 1995-09-04 2000-04-20 Steigerwald Arzneimittelwerk Process for the preparation of magnesium pyridoxal-5'-phosphate glutamate and intermediates obtained thereby
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
ES2250112T3 (en) 1999-03-08 2006-04-16 Medicure Inc. ANALOGS OF PIRIDOXAL FOR THE TREATMENT OF DISORDERS CAUSED BY THE LACK OF VITAMIN B6.
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
WO2001013900A2 (en) * 1999-08-24 2001-03-01 Medicure International Inc. Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
AU2001237185B2 (en) 2000-02-29 2006-02-02 Medicure International Inc. Cardioprotective phosphonates and malonates
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
WO2001072309A2 (en) 2000-03-28 2001-10-04 Medicure International Inc. Treatment of cerebrovascular disease
RU2163132C1 (en) * 2000-06-01 2001-02-20 Научно-исследовательский центр традиционной фитотерапии Method of treatment of patients with cardiovascular diseases with phytopreparation and medicinal species for treatment of patients with cardiovascular diseases
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
WO2002004421A2 (en) 2000-07-07 2002-01-17 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
CA2585165A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
JP2010535013A (en) 2007-03-14 2010-11-18 シエラ モレキュラー コーポレイション Compositions, systems and methods for storage and / or stabilization of cells and / or macromolecules
RU2484843C1 (en) * 2012-04-03 2013-06-20 Алексей Кириллович Пехтерев Medicinal herbal tea for cardiovascular diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE246172C (en)
DE2461742C2 (en) * 1974-12-28 1983-01-27 Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt Pyridoxine-5'-phosphoric acid ester derivatives and their preparation and pharmaceuticals containing these compounds
DE3807895A1 (en) * 1988-03-10 1989-09-21 Knoll Ag PRODUCTS CONTAINING A CALCIUM ANTAGONIST AND A LIPID DOWNER

Also Published As

Publication number Publication date
EP0458287B1 (en) 1996-09-18
DE4016963A1 (en) 1991-11-28
HUT58204A (en) 1992-02-28
DE4016963C2 (en) 1992-04-30
MD306B1 (en) 1995-10-31
UA26973A1 (en) 2000-02-28
EP0458287A3 (en) 1992-04-08
IE76728B1 (en) 1997-11-05
CA2043228C (en) 1998-07-14
CN1057391A (en) 1992-01-01
RU2041713C1 (en) 1995-08-20
SI9110925A (en) 1998-06-30
GR3021077T3 (en) 1996-12-31
IL98156A0 (en) 1992-06-21
AU7730191A (en) 1991-11-28
AU651108B2 (en) 1994-07-14
CA2043228A1 (en) 1991-11-26
ATE142884T1 (en) 1996-10-15
IL98156A (en) 1996-06-18
JPH07119174B2 (en) 1995-12-20
IN173057B (en) 1994-02-05
HRP931445B1 (en) 2000-04-30
HU219223B (en) 2001-03-28
LV10046B (en) 1995-02-20
LT3335B (en) 1995-07-25
HU911756D0 (en) 1991-12-30
ZA913692B (en) 1992-02-26
EG19730A (en) 1996-01-31
ES2091262T3 (en) 1996-11-01
DE69122170D1 (en) 1996-10-24
IE911783A1 (en) 1991-12-04
HRP931445A2 (en) 1996-02-29
US5372999A (en) 1994-12-13
CS156391A3 (en) 1992-02-19
SK278896B6 (en) 1998-04-08
MD306C2 (en) 1996-02-29
DE69122170T2 (en) 1997-02-20
EP0458287A2 (en) 1991-11-27
MX171883B (en) 1993-11-22
KR970005180B1 (en) 1997-04-14
JPH04235130A (en) 1992-08-24
CN1050750C (en) 2000-03-29
CZ280683B6 (en) 1996-04-17
KR910019616A (en) 1991-12-19
DK0458287T3 (en) 1996-10-07
LV10046A (en) 1994-05-10

Similar Documents

Publication Publication Date Title
LTIP580A (en) Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which results from vascular lesions
HUT66131A (en) Men's drawers
AU7397094A (en) Prevention and treatment of alzheimer's disease
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
IL106521A0 (en) Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure
ZA8993B (en) Medical treatment
AP9200355A0 (en) "Therapeutic agent"
TW223589B (en)
HU9502623D0 (en) Use of substituted alkyl-nitrates for the treatment of pathologically increased intraocular pressure
AU6678194A (en) Agents for the prevention and treatment of huntington's disease and other neurological disorders
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
NZ268039A (en) Use of efaroxan in treating parkinson's disease
AU114495S (en) Surgeon's hood
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
AU6955294A (en) Agents for the prevention and treatment of parkinson's disease
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
EG19885A (en) Medicament for the treatment of hyperlipidaemia and/or atherosolerosis
HUP0000476A3 (en) Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
IL88936A0 (en) Compositions for the prevention and treatment of periodontal disease
ITGE910094A0 (en) PRODUCT FOR THE TREATMENT AND PREVENTION OF CANCER AND AIDS
CA70342S (en) Surgeon's hood
CA2183764A1 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
ITMI942076A0 (en) PROCEDURE FOR THE REDUCTION OF NICOTINE CONTENT THROUGH THE ACTION OF MICROORGANISMS
AU115958S (en) Fisherman's apron
IL108924A0 (en) Compositions for the treatment of eye diseases

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20000531